Nanogels in Tumor Therapy

  • ChemPubSoc Europe Logo
  • Author: Andrei Dragan
  • Published Date: 02 March 2017
  • Source / Publisher: Chemistry – An Asian Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Nanogels in Tumor Therapy

Related Societies

Multidrug resistance (MDR), which allows tumors to evade anticancer drugs, is a serious issue in developing efficient chemotherapy approaches. As a vital contributor to drug resistance, over-expression of the membrane P-glycoprotein (P-gp) can result in reduced accumulation of chemotherapeutic agents in cancer cells. Therefore, effectively inhibiting P-gp and accumulating the therapeutics in tumors for enhanced treatment efficacy is highly important.


Bengang Xing, Nanyang Technological University, Singapore, and colleagues developed a smart stimulus-responsive self-assembled system for controlled drug release and simultaneous inhibition of P-gp function. The developed nanogel (pictured blue) combines a short peptide-Dox prodrug (PD) and the P-gp inhibitor (Verapamil, VER). The peptide sequence was prepared by Fmoc solid-phase synthesis and reacted further with Dox to form the PD, after which a mixture of the PD and VER self-assembled in water at 60 ºC.


These inhibitor-encapsulated nanogel enhances drug accumulation in resistant cancer cells. Importantly, the nanogels have significantly higher antitumor activity than free Dox drugs, thereby greatly reversing tumor resistance. According to the researchers, this work shows that self-assembly of bioactive agents with synergistic effects into nano-drugs could improve tumor therapy.


 

Article Views: 1243

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH